AlphaGrep UK’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Sell
2,880
-2,310
-45% -$239K 0.09% 489
2026
Q1
$502K Sell
5,190
-1,753
-25% -$180K 0.15% 243
2025
Q4
$737K Buy
+6,943
New +$805K 0.25% 85

Other funds holding EHC

AlphaGrep UK's EHC Position: Q2 2026 in Review

AlphaGrep UK reduced its Encompass Health (EHC) stake by 45% in Q2 2026, selling an estimated $239K and leaving 2,880 shares worth $291K. The position accounts for 0.09% of the portfolio, ranked #489.

AlphaGrep UK first reported a position in EHC in Q4 2025 and has held it in 3 quarters since. The position peaked at $737K in Q4 2025. 562 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • AlphaGrep UK held 2,880 shares of Encompass Health worth $291K as of Q2 2026.
  • AlphaGrep UK sold 2,310 Encompass Health shares in Q2 2026, an estimated $239K.
  • Encompass Health made up 0.09% of AlphaGrep UK's portfolio in Q2 2026, its #489 holding.
  • AlphaGrep UK first reported a position in Encompass Health in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Encompass Health position peaked at $737K in Q4 2025.
  • 562 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.